BIOGEN IDEC INC. 4

Accession 0001127602-15-011048

$BIIBCIK 0000875045operating

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 4:13 PM ET

Size

29.9 KB

Accession

0001127602-15-011048

Form 4

Period: 2015-03-10

Director

Transactions

Exercise/Conversion
Common Stock
2015-03-10$46.99/sh+3,125$146,844→ 17,998 total
Sale
Common Stock
2015-03-10$411.46/sh−300$123,439→ 17,498 total
Sale
Common Stock
2015-03-10$413.99/sh−1,000$413,985→ 15,798 total
Sale
Common Stock
2015-03-10$416.25/sh−525$218,530→ 14,973 total
Sale
Common Stock
2015-03-10$417.27/sh−100$41,727→ 14,873 total
Sale
Common Stock
2015-03-10$412.97/sh−700$289,078→ 16,798 total
Sale
Common Stock
2015-03-10$415.14/sh−300$124,543→ 15,498 total
Exercise/Conversion
Common Stock
2015-03-10$52.22/sh+500$26,110→ 15,373 total
Sale
Common Stock
2015-03-10$411.33/sh−100$41,133→ 14,873 total
Exercise/Conversion
Stock Option (Right to Buy)
2015-03-10−500→ 5,450 total
Exercise: $52.22Exp: 2017-05-30→ Common Stock (500 underlying)
Sale
Common Stock
2015-03-10$410.06/sh−400$164,022→ 14,973 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-10−3,125→ 0 total
Exercise: $46.99Exp: 2016-05-24→ Common Stock (3,125 underlying)
Sale
Common Stock
2015-03-10$410.61/sh−200$82,121→ 17,798 total

Footnotes (12)

[F1]Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
[F10]Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
[F11]Options will vest in their entirety on 05/25/2007 provided that the Reporting Owner is then a member of the Issuer's Board of Directors.
[F12]Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc.
[F2]Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
[F3]This represents the weighted average price for shares sold at a range between $410.18 (low) and $411.03 (high)
[F4]This represents the weighted average price for shares sold at a range between $411.35 (low) and $411.53 (high).
[F5]This represents the weighted average price for shares sold at a range between $412.47 (low) and $413.18 (high).
[F6]This represents the weighted average price for shares sold at a range between $413.62 (low) and $414.28 (high).
[F7]This represents the weighted average price for shares sold at a range between $414.82 (low) and $415.71 (high).
[F8]This represents the weighted average price for shares sold at a range between $415.90 (low) and $416.54 (high).
[F9]This represents the weighted average price for shares sold at a range between $409.67 (low) and $410.35 (high).

Documents

2 files

BIOGEN IDEC INC.

CIK 0000875045

Entity typeoperating

IncorporatedDE